查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1570758

全球乳癌診斷市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢和預測

Global Breast Cancer Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

全球乳癌診斷市場需求預計將從 2023 年的 52.2 億美元達到近 104.7 億美元的市場規模，2024-2032 年研究期間複合年成長率為 8.05%。

乳癌診斷涉及一系列用於分階段識別和評估乳癌的技術和工具。該領域結合了乳房X光攝影、超音波和MRI、活體組織切片程序和分子檢測等影像方法，以實現準確的診斷和分期。這些診斷方法起到了檢測作用，大大提高了治療的前景和效果。現代診斷策略通常會結合多種技術來提高敏感性和特異性，使醫療保健提供者能夠在正確的階段發現腫瘤。該領域的最新進展包括用於精確3D成像的乳房斷層合成以及用於檢查循環腫瘤 DNA 以進行非侵入性癌症檢測的液體活體組織切片。這種整體方法確保個人化治療計劃，最終導致患者的治療結果和個人化醫療的進步。

市場動態

乳癌診斷市場是由多種因素推動的，包括乳癌發生率的增加、診斷技術的進步以及早期檢測意識的提高。這種不斷增加的負擔凸顯了對增強診斷工具和服務的需求。 MRI、數位乳房 X 光攝影和創新生物標記等技術進步正在改變診斷方式、改善早期檢測並提高診斷準確性。例如，人工智慧在影像領域的發展正在顯著提高乳癌檢測的精度。西門子醫療 (Siemens Healthineers) 和通用電氣醫療 (GE Healthcare) 等主要參與者正在整合人工智慧演算法，以支援放射科醫生更準確、更有效率地識別異常情況。個人化醫療的日益普及進一步推動了市場機會，這需要先進的診斷工具來為個別患者提供個人化治療。新一代定序技術和液體活體組織切片的實施正在為非侵入性監測和精確診斷創造新途徑，從而擴大乳癌診斷市場。

醫療保健研發支出的不斷增加也推動了市場的成長。例如，羅氏診斷公司最近推出了一種新的乳癌檢測方法，利用先進的分子分析來指導治療決策，代表著向精準和個人化醫療邁出的策略性舉措。此外，主要市場參與者之間的夥伴關係和協作正在推動創新。隨著市場參與者繼續在尖端研究和開發上投入資金，乳癌診斷市場預計將顯著成長，新的診斷解決方案將增強早期檢測和治療選擇。然而，先進診斷技術的高成本和資源匱乏環境中的取得機會有限阻礙了市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球乳癌診斷市場的每個細分市場進行了包容性評估。乳癌診斷產業的成長和趨勢為這項研究提供了整體方法。

市場區隔

乳癌診斷市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按類型

  • 影像學
  • 活體組織切片
  • 基因組測試
  • 血液檢查
  • 其他

按產品分類

  • 基於平台的產品（下一代定序、微陣列、PCR 等）
  • 以儀器為基礎的產品（影像、切片）

按申請

  • 篩選
  • 診斷和預測
  • 預後
  • 研究

按最終用途

  • 醫院和診所
  • 診斷中心和醫學實驗室
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲乳癌診斷市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。乳癌診斷市場的主要參與者包括 Hologic Inc.、Genomic Health (Exact Sciences Corporation)、BD、Danaher、Koninklijke Philips NV、QIAGEN、Thermo Fisher Scientific Inc.、Myriad Genetics Inc.、Argon Medical Devices Inc.、F霍夫曼-拉羅氏有限公司。 。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：乳癌診斷 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按類型分類的市場吸引力分析
    • 按產品分類的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 按最終用途分類的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球乳癌診斷市場分析：按類型

  • 按類型概述
  • 按類型分類的歷史和預測資料分析
  • 影像學
  • 活體組織切片
  • 基因組測試
  • 血液檢查
  • 其他

第 6 章：全球乳癌診斷市場分析：按產品

  • 概述（按產品）
  • 按產品分類的歷史和預測資料分析
  • 基於平台的產品（下一代定序、微陣列、PCR 等）
  • 以儀器為基礎的產品（影像、切片）

第 7 章：全球乳癌診斷市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據分析：按應用
  • 篩選
  • 診斷和預測
  • 預後
  • 研究

第 8 章：全球乳癌診斷市場分析：依最終用途分類

  • 按最終用途分類的概述
  • 按最終用途分類的歷史和預測資料分析
  • 醫院和診所
  • 診斷中心和醫學實驗室
  • 其他

第 9 章：全球乳癌診斷市場分析：按地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：乳癌診斷公司的競爭格局

  • 乳癌診斷市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Hologic Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Genomic Health (Exact Sciences Corporation)
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • BD
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Danaher
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Koninklijke Philips NV
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • QIAGEN
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Myriad Genetics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Argon Medical Devices Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • F. Hoffmann-La Roche Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR112115626

The global demand for Breast Cancer Diagnostics Market is presumed to reach the market size of nearly USD 10.47 Billion by 2032 from USD 5.22 Billion in 2023 with a CAGR of 8.05% under the study period 2024-2032.

Breast cancer diagnostics involves a range of techniques and tools used to identify and evaluate breast cancer at phases. This area combines imaging methods, like mammography, ultrasound and MRI, biopsy procedures, and molecular testing to achieve accurate diagnosis and staging. These diagnostic methods play a role in detection, which greatly improves the outlook and effectiveness of treatment. Modern diagnostic strategies often merge techniques to improve sensitivity and specificity, allowing healthcare providers to spot tumors at the right stage. Recent advancements in this field include breast tomosynthesis for precise three-dimensional imaging and liquid biopsies that examine circulating tumor DNA for noninvasive cancer detection. This holistic approach ensures personalized treatment plans, ultimately leading to patient outcomes and progress in personalized medicine.

Market Dynamics

The breast cancer diagnostics market is driven by a combination of factors, including increasing incidence of breast cancer, advancements in diagnostic technology, and heightened awareness about early detection. This rising burden underscores the need for enhanced diagnostic tools and services. Technological advancements such as MRI, digital mammography, and innovative biomarkers are transforming diagnostics, improving early detection, and enhancing diagnostic accuracy. For instance, the development of AI in imaging is significantly propelling the precision of breast cancer detection. Key players like Siemens Healthineers & GE Healthcare are incorporating AI algorithms to support radiologists in identifying anomalies with greater accuracy and efficiency. Market opportunities are further propelled by the growing adoption of personalized medicine, which requires advanced diagnostic tools for personalized treatments for individual patients. The implementation of next-generation sequencing technologies and liquid biopsies is creating new avenues for noninvasive monitoring and precise diagnosis, thus expanding the breast cancer diagnostics market.

The escalating healthcare spending in research and development is also fuelling market growth. For instance, Roche Diagnostics has recently introduced a new breast cancer assay that leverages advanced molecular profiling to guide treatment decisions, representing a strategic move towards precision and personalized medicine. In addition, partnerships and collaborations among key market players are driving innovation. As market players continue to spend on cutting-edge research and development, the breast cancer diagnostics market is projected for significant growth, with new diagnostic solutions enhancing early detection and treatment options. However, high costs concerned with advanced diagnostic technologies and limited access in low-resource settings hamper market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Breast Cancer Diagnostics. The growth and trends of Breast Cancer Diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Breast Cancer Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Imaging
  • Biopsy
  • Genomic Tests
  • Blood Tests
  • Others

By Product

  • Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others)
  • Instrument-based Products (Imaging, Biopsy)

By Application

  • Screening
  • Diagnostic and Predictive
  • Prognostic
  • Research

By End-use

  • Hospitals & Clinics
  • Diagnostic Centers and Medical Laboratories
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Breast Cancer Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Breast Cancer Diagnostics market include Hologic Inc., Genomic Health (Exact Sciences Corporation), BD, Danaher, Koninklijke Philips N.V., QIAGEN, Thermo Fisher Scientific Inc., Myriad Genetics Inc., Argon Medical Devices Inc., F. Hoffmann-La Roche Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. BREAST CANCER DIAGNOSTICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End-use
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Imaging Historic and Forecast Sales By Regions
  • 5.4. Biopsy Historic and Forecast Sales By Regions
  • 5.5. Genomic Tests Historic and Forecast Sales By Regions
  • 5.6. Blood Tests Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data Analysis By Product
  • 6.3. Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others) Historic and Forecast Sales By Regions
  • 6.4. Instrument-based Products (Imaging, Biopsy) Historic and Forecast Sales By Regions

7. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Screening Historic and Forecast Sales By Regions
  • 7.4. Diagnostic and Predictive Historic and Forecast Sales By Regions
  • 7.5. Prognostic Historic and Forecast Sales By Regions
  • 7.6. Research Historic and Forecast Sales By Regions

8. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ANALYSIS BY END-USE

  • 8.1. Overview By End-use
  • 8.2. Historical and Forecast Data Analysis By End-use
  • 8.3. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 8.4. Diagnostic Centers and Medical Laboratories Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL BREAST CANCER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE BREAST CANCER DIAGNOSTICS COMPANIES

  • 10.1. Breast Cancer Diagnostics Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF BREAST CANCER DIAGNOSTICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Hologic Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Genomic Health (Exact Sciences Corporation)
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. BD
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Danaher
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Koninklijke Philips N.V.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. QIAGEN
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Thermo Fisher Scientific Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Myriad Genetics Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Argon Medical Devices Inc.
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. F. Hoffmann-La Roche Ltd
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Imaging Market Sales By Geography (USD MN)
  • Biopsy Market Sales By Geography (USD MN)
  • Genomic Tests Market Sales By Geography (USD MN)
  • Blood Tests Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Product (USD MN)
  • Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others) Market Sales By Geography (USD MN)
  • Instrument-based Products (Imaging, Biopsy) Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Screening Market Sales By Geography (USD MN)
  • Diagnostic and Predictive Market Sales By Geography (USD MN)
  • Prognostic Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Analysis By End-use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Diagnostic Centers and Medical Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Breast Cancer Diagnostics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Breast Cancer Diagnostics Report
  • Market Research Process
  • Market Research Methodology
  • Global Breast Cancer Diagnostics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End-use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Imaging Market Sales By Geography (USD MN)
  • Biopsy Market Sales By Geography (USD MN)
  • Genomic Tests Market Sales By Geography (USD MN)
  • Blood Tests Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Product (USD MN)
  • Platform-based Products (Next-generation Sequencing, Microarrays, PCR, Others) Market Sales By Geography (USD MN)
  • Instrument-based Products (Imaging, Biopsy) Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Screening Market Sales By Geography (USD MN)
  • Diagnostic and Predictive Market Sales By Geography (USD MN)
  • Prognostic Market Sales By Geography (USD MN)
  • Research Market Sales By Geography (USD MN)
  • Global Market Analysis By End-use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Diagnostic Centers and Medical Laboratories Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.